DJIA 18,070.40 46.34 0.26%
NASDAQ 5,016.93 11.54 0.23%
S&P 500 2,114.49 6.20 0.29%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

59.66 1.42 (2.44%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $59.66 2.44%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $60.00
Previous Close $58.24
Daily Range $58.94 - $62.21
52-Week Range $22.25 - $77.80
Market Cap $7.1B
P/E Ratio -176.48
Dividend (Yield) $0.00 (0.0%)
Volume 5,293,100
Average Daily Volume 2,731,181
Current FY EPS -$0.79




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary

The Best Way to Invest Money in an Aging Population

According to the latest report from the CDC, Americans are living longer than ever. If you're an investor, one sector offers you the best way to invest money in America's aging population.

Will Isis Pharmaceuticals (ISIS) Disappoint in Q1 Earnings? - Analyst Blog

ISIS Pharmaceuticals Cuts License Deal With Bayer AG

Jim Cramer -- Isis Pharma Deal With Bayer Is Huge; Avoid Tesla

Noteworthy ETF Outflows: IWM, QRVO, ISIS, PBYI

Sonic Is Down Too Much - Cramer's Lightning Round (4/30/15)

Idera Pharmaceuticals: Is The Writing On The Wall?

Isis Pharmaceuticals' ISIS-TTR Effective in Extension Study - Analyst Blog

Alnylam Strengthens Its Clinical Case Once Again

Analysts Provide Update for Biogen, PTC Therapeutics, GW Pharma, and Isis Pharma

See More ISIS News...

ISIS's Top Competitors

ISIS $59.66 (2.44%)
Current stock: ISIS
AMGN $162.11 (1.09%)
Current stock: AMGN
GILD $105.66 (0.62%)
Current stock: GILD
BIIB $386.22 (0.00%)
Current stock: BIIB